| 1. Why do "Long COVID" and mRNA vaccine injury share the same underlying mechanism—the intrinsic toxicity of the spike protein and its interaction with ACE-2 and other receptors—yet are treated in public discourse as entirely separate phenomena? | 7. Why were PCR cycle thresholds commonly run at 35–40 cycles (including CDC studies at ~40 cT), when the WHO advised hospitals to use thresholds under 35 to reduce false positives? How did this inflate case counts, and why was Florida the only state legally required to report cycle thresholds? |
| 2. What accounts for the sharp post-vaccination increase in strokes and thrombotic events documented in "spikeopathy" research—and why do these findings align with what morticians reported in documentaries such as Died Suddenly? | 8. How did the distinction between dying with COVID (a positive PCR at time of death) and dying from COVID affect mortality statistics—and who benefited when that line was blurred? |
| 3. Why did Pfizer's own confidential post-marketing adverse events report (Document 5.3.6) document alarming cardiovascular and other adverse events (pages 8 and 16)—and how do those rates compare to pharmaceuticals such as Vioxx that were withdrawn from the market? | 9. Why were U.S. hospitals reportedly paid $13,000 per COVID diagnosis and an additional $39,000 per patient placed on a ventilator? What federal authorization enabled these incentives, and how did they shape treatment protocols—including the use of Remdesivir? |
| 4. How does spike protein interaction with tumor suppressors p53 BP1 and BRCA1 relate to the reported rise in aggressive "turbo cancers" following mass vaccination campaigns? Why has this pathway received limited mainstream investigation? | 10. What role did Anthony Fauci, Peter Daszak, the NIH, and EcoHealth Alliance play in funding and overseeing gain-of-function or related coronavirus research—and what was disclosed versus concealed before and during the pandemic? |
| 5. What is antibody-dependent enhancement (ADE), and why was it flagged as a risk during coronavirus vaccine development yet largely absent from public risk-benefit discussions once mass rollout began? | 11. Why was the definition of "vaccine" changed in September 2022, and how did that semantic shift enable "No Jab, No Job" policies that would have been legally or ethically untenable under the prior definition? |
| 6. What evidence exists for spike protein "shedding" affecting unvaccinated individuals, and what are the implications for species-wide reproductive health when lipid nanoparticles and mRNA mechanisms distribute spike production throughout the body? | 12. How was VAERS data collected, filtered, and reported—and what substantive evidence suggests undercounting, delayed reporting, or systematic manipulation? Who gains when adverse event databases are minimized in public messaging? |